|
Phase III randomized controlled study of daratumumab, bortezomib, and dexamethasone (DVd) versus bortezomib and dexamethasone (Vd) in patients (pts) with relapsed or refractory multiple myeloma (RRMM): CASTOR study. |
|
|
No Relationships to Disclose |
|
Asher Alban Akmal Chanan-Khan |
No Relationships to Disclose |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Onyx; Takeda |
Research Funding - Celgene; Janssen |
|
|
Consulting or Advisory Role - Novartis; Onyx; Spectrum Pharmaceuticals |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen-Cilag; Novartis; Takeda |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen-Cilag; Novartis |
|
|
Honoraria - Amgen; Celgene; Janssen |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen |
|
|
Consulting or Advisory Role - Janssen; Takeda |
|
|
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; Takeda |
|
|
Stock and Other Ownership Interests - Abbvie |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Takeda |
Research Funding - Amgen; Celgene; Takeda |
|
|
Employment - Johnson & Johnson |
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson; Merck |
|
|
No Relationships to Disclose |
|
|
Employment - Johnson & Johnson |
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Johnson & Johnson |
|
|
Honoraria - Janssen-Cilag |
Consulting or Advisory Role - Janssen-Cilag |
Speakers' Bureau - Janssen-Cilag |
Research Funding - Janssen-Cilag |
|
|
Honoraria - Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Research Funding - Amgen; Celgene; Janssen; Karyopharm Therapeutics |